« Previous
Next »
Injury
Volume 41, Issue 7
, Pages 717-723
, July 2010
Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs
References
- . Investigation of platelet-rich plasma in rabbit cranial defects: a pilot study. J Oral Maxillofac Surg. 2002;60:1176–1181
- . Human platelet-derived growth factor (PDGF): purification of PDGF-I and PDGF-II and separation of their reduced subunits. Proc Natl Acad Sci USA. 1981;78:7314–7317
- One systemic administration of transforming growth factor-beta 1 reverses age- or glucocorticoid-impaired wound healing. J Clin Invest. 1993;92:2841–2849
- . Production of platelet-derived growth factor-like molecules and reduced expression of platelet-derived growth factor receptors accompany transformation by a wide spectrum of agents. Proc Natl Acad Sci USA. 1984;81:2396–2400
- Platelet-rich plasma and bovine porous bone mineral combined with guided tissue regeneration in the treatment of intrabony defects in humans. J Periodontal Res. 2002;37:300–306
- Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am. 2007;89:2413–2420
- Platelet-rich plasma may not provide any additional effect when associated with guided bone regeneration around dental implants in dogs. Clin Oral Implants Res. 2007;18:649–654
- . The diagnostic value of the new method for the study of undecalcified bones and teeth with attached soft tissue (Sage-Schliff (sawing and grinding) technique). Pathol Res Pract. 1985;179:631–633
- . Osteogenic protein-1 in treatment of tibial nonunions: current status. Surg Technol Int. 2004;13:249–252
- Effects of fibrin sealant protein concentrate with and without platelet-released growth factors on bony healing of cortical mandibular defects. An experimental study in minipigs. Clin Oral Implants Res. 2004;15:301–307
- Effect of platelet-released growth factors and collagen type I on osseous regeneration of mandibular defects. A pilot study in minipigs. J Clin Periodontol. 2004;31:784–790
- . The use of platelet-rich plasma to enhance the success of bone grafts around dental implants. Dent Implantol Update. 2000;11:17–21
- . Bone substitutes: an update. Injury. 2005;36(Suppl. 3):S20–27
- Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am. 2002;84-A:2123–2134
- . Platelet rich plasma and fresh frozen bone allograft as enhancement of implant fixation. An experimental study in dogs. J Orthop Res. 2004;22:653–658
- Transplantation of marrow-derived mesenchymal stem cells and platelet-rich plasma during distraction osteogenesis—a preliminary result of three cases. Bone. 2004;35:892–898
- . Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration. Surgery. 1981;90:262–270
- . Available biological treatments for complex non-unions. Injury. 2007;38(Suppl. 4):S7–12
- . Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg. 2004;62:489–496
- Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638–646
- . “Mandibular and facial reconstruction” rehabilitation of the head and neck cancer patient. Bone. 1996;19:59S–82S
- . The mechanism of action of transforming growth factor-beta. Gastroenterol Jpn. 1993;28(Suppl. 4):81–85[discussion 86–7]
- . Bone growth factors. Clin Orthop Relat Res. 1991;30–48
- Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol. 1992;140:1375–1388
- Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. Biomaterials. 2006;27:1817–1823
- . Bone substitutes. Unfallchirurg. 2008;111:613–619[quiz 620]
- Osseous defect regeneration using autogenous bone alone or combined with Biogran or Algipore with and without added thrombocytes. A microradiologic evaluation. Mund Kiefer Gesichtschir. 2003;7:112–118
- Guided bone regeneration at dehiscence-type defects using biphasic hydroxyapatite
+
beta tricalcium phosphate (Bone Ceramic) or a collagen-coated natural bone mineral (BioOss Collagen): an immunohistochemical study in dogs. Int J Oral Maxillofac Surg. 2007;36:1198–1206 - . Phylogenetic analysis of platelet-derived growth factor by radio-receptor assay. J Cell Biol. 1982;95:667–671
- . Early bone formation in human bone grafts treated with platelet-rich plasma: preliminary histomorphometric results. Int J Oral Maxillofac Surg. 2007;36:1164–1171
- . Growth factors—BMPs, DBMs, and buffy coat products: are there any proven differences amongst them?. Injury. 2007;38(Suppl. 1):S38–S48
- Growth stimulation of human osteoblast-like cells by thrombocyte concentrates in vitro. Mund Kiefer Gesichtschir. 2002;6:168–174
- Grafting of massive tibial subchondral bone defects in a caprine model using beta-tricalcium phosphate versus autograft. J Orthop Trauma. 2005;19:85–91
- . Current opinion about using the platelet-rich gel in orthopaedics and trauma surgery. Ortop Traumatol Rehabil. 2007;9:227–238
- Clinical experience with bone morphogenetic protein 7 (BMP 7) in nonunions of long bones. Unfallchirurg. 2006;109:528–537
PII: S0020-1383(09)00645-7
doi: 10.1016/j.injury.2009.12.005
© 2009 Elsevier Ltd. All rights reserved.
« Previous
Next »
Injury
Volume 41, Issue 7
, Pages 717-723
, July 2010
